For the second day in a row, the number of active COVID-19 cases remained below 9 lakh.
The Indira Gandhi National Open University invites applications for its Post Graduate Diploma In Community Cardiology programme.
'Our future is in limbo. The government saved us with Operation Ganga; now, they must save our careers.'
The coronavirus caseload surged to 56,46,010, while the death toll climbed to 90,020 with 1,085 people succumbing to the disease in a span of 24 hours, the data updated at 8 am showed.
The COVID-19 case fatality rate stood at 1.43 per cent.
With 13,052 new coronavirus infections being reported in a day, India's COVID-19 tally has gone up to 1,07,46,183, while the number of people who have recuperated from the disease has surged to 1,04,23,125, according to the Union health ministry data updated on Sunday.
The total coronavirus cases mounted to 94,99,413, with 36,604 new infections being reported in a day, while the death toll climbed to 1,38,122 with 501 new fatalities, the data updated at 8 am showed.
The total coronavirus cases mounted to 52,14,677, while the death toll climbed to 84,372 with the virus claiming 1,174 lives in a span of 24 hours, the data updated at 8 am showed.
The total coronavirus cases mounted to 93,92,919 with 41,810 new infections being reported in a day, while the death toll climbed to 1,36,696 with 496 new fatalities, the data updated at 8 am showed.
These kinds of assumptions to be used for a nation of India's size and "to put us in poor light is not desirable"
According to respective company sources, Biological E is holding 200 million doses of its COVID-19 vaccine Corbevax while Bharat Biotech is sitting on a stockpile of 50 million doses of Covaxin.
The number of active cases remained below 5 lakh for the second consecutive day.
India's COVID-19 tally had crossed the 20-lakh mark on August 7, 30 lakh on August 23 and 40 lakh on September 5. It went past 50 lakh on September 16, 60 lakh on September 28 and crossed 70 lakh on October 11.
India is currently using two vaccines for COVID-19 -- one developed by Oxford University and AstraZeneca and the other developed by Bharat Biotech in collaboration with the Indian Council of Medical Research-National Institute of Virology. Both the vaccines are being manufactured within the country by domestic firms.
The death toll climbed to 4,98,983 with 1,008 fresh fatalities, including 500 from Kerala, the data updated at 8 am stated.
A total of 1,525 cases of Omicron variant of coronavirus have been detected across 23 states and Union Territories so far, out of which 560 have recovered or migrated, according to the Union health ministry's data updated on Sunday.
A total of 13,993 new cases were registered in a span of 24 hours. The death toll increased to 101 daily new fatalities, the data updated at 8 am showed.
The number of people who have recuperated from the disease surged to 1,01,29,111 pushing the national COVID-19 recovery rate to 96.51 per cent, while the COVID-19 case fatality rate stands at 1.44 per cent.
This is also the highest daily rise in the last 83 days. As many as 26,624 new infections were recorded on December 20.
There has been a 4.36 per cent increase in Omicron cases since Thursday, the ministry said.
The total coronavirus cases mounted to 64,73,544 with 79,476 new infections being reported in a day, while the death toll climbed to 1,00,842 with the virus claiming 1,069 lives in a span of 24 hours, data updated at 8 am showed.
The number of active cases of COVID-19 remained below 6 lakh for the ninth consecutive day.
The daily rise in new coronavirus infections has been recorded below 15,000 for the last 53 days now.
The active Covid cases have declined to 9,94,891, comprising 2.35 per cent of the total infections.
Registering an upward trend for five days in a row, the total active caseload has gone up to 2,19,262 which is 1.93 per cent of the total infections in the country, while the recovery rate has dropped to 96.68 per cent, the data stated.
The daily positivity rate was recorded at 2.50 per cent and the weekly positivity rate was 2.63 per cent. It has been below three per cent for the last 71 days.
The country's active caseload increased to 2,10,544 and constitutes 1.85 per cent of the total infections. The recovery rate dropped to 96.75 per cent from 96.82 per cent on Saturday.
The active cases comprise 0.43 per cent of the total infections, the lowest since March last year.
The number of people who have recovered from the disease has risen to 3,02,69,796, while the case fatality rate has increased to 1.33 per cent, the data stated.
The number of active cases has declined to 6,27,057 and is 2.08 per cent of the total infections.
The COVID-19 active caseload remained below 3 lakh on Saturday.
A total of 1,660 fresh cases have pushed the country's COVID-19 tally to 4,30,18,032, while the number of active cases has fallen below 20,000, according to the ministry's data updated at 8 am.
The government is taking the cutoff of about 100 days if reinfection occurs.
The active cases have increased to 18,31,000, the highest in 232 days.
The total tally of COVID-19 cases mounted to 1,50,61,919 and the death toll increased to 1,78,769 with a record 1,619 daily new fatalities, the data updated at 8 am showed.
COVID-19 is on the verge of becoming endemic but Indian scientists are keeping a close watch on each new variant and the government would continue to maintain a high alert, Union health minister Mansukh Mandaviya has said, underlining that the virus has managed to survive and is going to stay.
Registering a steady increase for the 34th day in a row, the number of active cases rose to 12,64,698, or 9.24 per cent of the total infections.
India could lose over $130 billion annually, if western countries were allowed to exploit and dilute ayurveda, one of the trusted age-old Indian medicine system, experts say.
For six days in a row the active cases of COVID-19 remained below 9 lakh.
© 2026 Rediff.com - Investor Information - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances